Journal Menu► ▼ Journal Menu
Journal Browser► ▼ Journal Browser
Special Issue "Osteoporosis 2.0"
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 30 August 2023 | Viewed by 613
Special Issue Editor
Interests: osteoporosis; metabolic bone diseases; parathyroid diseases; multiple endocrine neoplasia; genetic diseases of bone
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Osteoporosis still represents a pathological condition that remains largely underdiagnosed and undertreated, mainly due to the low frequency of screening and the controversies in BMD testing standards. Testosterone, estrogen, SHBG, and FSH levels interact in determining bone mass accrual, BMD maintenance, and lifetime decrease.
As a general example of this, in recent decades the global rise in obesity and sedentary lifestyles, together with an aging population, lead to the increased incidence and prevalence of type 2 diabetes, a known major cause of disability, socioeconomic costs, and increased risk of all-cause mortality. Fragility fractures are increasingly recognized as an important complication of T2DM. Osteoporosis is often an underdiagnosed T2DM-related complication.
The appropriate early diagnosis of osteoporosis is mandatory in order to start the adequate treatment of these subjects, representing a very important step in clinical practice as it may impact mortality more in women.
This Special Issue aims to update the pathophysiology and preclinical approach to osteoporosis and overall fracture risk, including humans affected by dysmetabolism, systemic disorders, and with or without type 2 diabetes, to move the field forward and suggest how to decrease the fracture rate in specific clinical scenarios.
We welcome both original research and review articles.
Dr. Alberto Falchetti
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- fractures in T2DM
- preclinical and instrumental diagnostic tools of bone fragility
- pathogenesis of bone fragility
- biomarkers predictive of bone mass reduction as well as bone fragility
- prevention of fractures
- the role of antidiabetic drugs in bone health and fracture rate
- the effects of antiosteoporotic drugs
Related Special Issue
- Osteoporosis in International Journal of Molecular Sciences (12 articles)